When accounting for statistical imbalances in the number of micro- and macroadenomas in male patients using a data augmentation method (SMOTE), differences in gender-specific prolactin thresholds with respect to adenoma size remained, with male-specific thresholds being significantly higher (Supplementary Table S1). The gene discussed is PRL; the disease is adenoma.